ArticleBMC cardiovascular disorders2017

Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed.

Herbert J A Rolden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.